|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23-24
|
|
pubmed:dateCreated |
2009-6-16
|
|
pubmed:abstractText |
Serum cystatin C (CysC) is a marker for kidney function, possibly superior to serum creatinine (Cr). Cr is increased and CysC decreased in primary hypothyroidism; these changes are reversed upon thyroxine (T4) replacement therapy. This (pilot) study was performed to see whether these opposing changes of CysC and Cr could be confirmed in patients with central hypothyroidism.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1424-7860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
13
|
|
pubmed:volume |
139
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
339-44
|
|
pubmed:dateRevised |
2011-2-15
|
|
pubmed:meshHeading |
pubmed-meshheading:19529992-Adult,
pubmed-meshheading:19529992-Biological Markers,
pubmed-meshheading:19529992-Creatinine,
pubmed-meshheading:19529992-Cystatin C,
pubmed-meshheading:19529992-Female,
pubmed-meshheading:19529992-Hormones,
pubmed-meshheading:19529992-Humans,
pubmed-meshheading:19529992-Hypothyroidism,
pubmed-meshheading:19529992-Male,
pubmed-meshheading:19529992-Middle Aged,
pubmed-meshheading:19529992-Pituitary Neoplasms,
pubmed-meshheading:19529992-Prospective Studies,
pubmed-meshheading:19529992-Thyroiditis, Autoimmune,
pubmed-meshheading:19529992-Thyroxine
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism.
|
|
pubmed:affiliation |
Division of Endocrinology & Diabetes, Department of Internal Medicine, Kantonsspital St Gallen, St Gallen, Switzerland. d.goede@vumc.nl
|
|
pubmed:publicationType |
Journal Article
|
